Oncology Business Management | Specialty

The OncLive Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.


Keeping Patients in Mind: Noted Breast Cancer Researcher Pursues Broad Notion of Personalized Medicine

December 28th 2011

One of a small group of scientists who had a hand in developing Herceptin (trastuzumab) for the treatment of breast cancer, Dr. Debu Tripathy's current work is focused on understanding why some patients are resistant to the drug, and how to create more effective therapies for them.

Doxil Shortage Expected to Last Another Year

December 27th 2011

Johnson and Johnson announced that they do not expect more Doxil (doxorubicin HCl liposome injection) to be available until sometime late in 2012...

Exploiting Oncogene Addiction and Immunogenicity May Be Path to Improved Results in HER2-Positive Breast Cancer

December 27th 2011

The approval of trastuzumab, targeted directly to the human epidermal growth factor receptor (HER2)-positive, was a major advance in extending the lives of women with HER2-positive breast cancer.

Room for Improvement: Reporting Near-Misses and Errors in Radiation Oncology

December 27th 2011

A new study presented at the 2011 annual meeting of the American Society for Radiation Oncology (ASTRO) found that 97% of radiation oncology team members believe they have a responsibility to report near-misses and errors...

The FDA Revokes

December 21st 2011

The FDA has broad authority to regulate food safety, as well as the safety, efficacy, and utilization of drugs and medical devices.

Day in the Life of an Oncology/Hematology Fellowship Program Director

December 15th 2011

Trainees have sat in this hot seat at the front of the room for decades. It's not really warm, of course. This is where the fellow sits who is asked to review the findings, come up with a differential diagnosis, and devise a plan for the case in question.

Interviewing 101: Tips for Landing Your First Post-Fellowship Position

December 15th 2011

Like all the other skills you've honed so finely over the years, interviewing can be mastered with the help of some solid tips, ample preparation, and a good dose of practice.

What Oncology and Hematology Fellows Can Do to Reduce Their Loan Debt

December 15th 2011

While debt from medical school loans is inevitable for most oncology and hematology fellows, there are strategies they can consider to lessen that burden.

Progenics Trims Staff to Focus on Oncology

November 30th 2011

Progenics Pharmaceuticals, Inc. is trimming its staff by 26% and cutting its infectious disease and virology programs so that it can focus solely on its oncology program.

Dr. Brufsky Advises Doctors on Avastin for Breast Cancer

November 18th 2011

Dr. Adam Brufsky from the University of Pittsburgh School of Medicine Advises Doctors on Bevacizumab (Avastin) for Breast Cancer

Dr. Woodruff on Oncofertility Insurance Coverage

November 2nd 2011

Dr. Teresa Woodruff from Feinberg School of Medicine, Northwestern University, Discusses Oncofertility Insurance Coverage

Loan Repayment Programs for Oncology/Hematology Fellows

October 31st 2011

It’s no surprise that you acquire significant debt during your medical training. Here are some ways to get those loans paid off.

The Biology of Burnout

October 31st 2011

Burnout is a recurring problem for overworked oncologists and hematologists. This article includes ideas to keep you healthy, engaged, and empathic.

How to Perform the Perfect Bone Marrow Biopsy

October 31st 2011

Obtaining a high-quality bone marrow aspirate and biopsy is very important for the patient—and for you. Following these general guidelines will help you do this successfully.

Public Speaking Tips for Fellows

October 31st 2011

All fellows will at some point in their careers be required to speak in public. This article provides a number of tips to make that task easier.

Physicians Uniting to Battle Flawed Medicare Reimbursement Formula

October 24th 2011

As millions of Americans grapple with changes in Medicare and other health insurance coverage, thousands of oncologists could find their medical practices threatened by insolvency.

A Ponzi Scheme: Investments, Social Security, Healthcare

October 19th 2011

Here are a few incontrovertible facts: our population is growing and aging; people are living longer; and care is more complex and applied for longer periods, so it is more costly.

Dr. Langer on Cost Analysis in the Treatment Decision

October 13th 2011

Dr. Corey Langer from Abramson Cancer Center on Cost Analysis in the Treatment Decision

Oncogenic Signaling of the EGFR: Familiar Target Faces New Questions

October 3rd 2011

The epidermal growth factor receptor (EGFR) is the prototypical receptor tyrosine kinase (RTK) and one of the most comprehensively studied molecular targets in clinical oncology.

New Frontiers in the Management of Solid and Liquid Tumors Letter from Andre Goy, MD, MS

October 1st 2011

A Letter from Andre Goy, MD, MS, about the New Frontiers in the Management of Solid and Liquid Tumors in November.

NEXT PAGE
PREVIOUS PAGE